Kory James Wentworth, CFO: Entrada Therapeutics TRDA Sell · Filed 23/06/23

Trade details

Type: Insider sale
Amount: $135,119.19
Shares · price: 8,907 sh · $15.17 a share
Held after: 27,957 sh
Stock: Entrada Therapeutics TRDA
Person: Kory James WentworthCFO
Trade date: 23/06/21
Filed: 23/06/23
Days to filing: 2 days

Sold 24.2% of holdings

Share of holding sold: 24.2%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 23/05/22~23/07/21

Kory James Wentworth's recent trades

Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$32.4K
2,500 sh
$32.4K
Filed 04/02
Traded 04/01
Kory James WentworthCFO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$31.6K
2,500 sh
$31.6K
Filed 04/01
Traded 04/01
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$148.3K
11,388 sh
$148.3K
Filed 03/11
Traded 03/10
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$66.2K
5,089 sh
$66.2K
Filed 03/11
Traded 03/09
Kory James WentworthCFO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$207.3K
16,477 sh
$207.3K
Filed 03/09
Traded 03/09

Kory James Wentworth, CFO — sold $135.1K of Entrada Therapeutics TRDA · 24.2% of holdings · 10b5-1 plan | Whalegun